Pediatrics Medical News about tuberous sclerosis

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors
Pediatric Blood & Cancer, 10/30/09

Lam C et al. – Tuberous sclerosis complex is associated with hamartomatous growths including subependymal giant cell astrocytomas. Since chemo–radiation therapies offer scant benefit, oncologists had traditionally been little involved in managing SEGAs. Recent evidence demonstrating rapamycin efficacy in adults and children with TSC–associated tumors foresee a practice change.

<< Previous
Oral Ibuprofen and Ductus Arteriosus Closure in Full-Term...

Next >>
Pediatrician's responses to an evidence summary about renal tract...

Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09 Relevance Score: 47%

Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09 Relevance Score: 44%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09 Relevance Score: 44%

A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09 Relevance Score: 44%

Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09 Relevance Score: 43%